Clinical trial
Safety and Acceptability of a Vaginal Microbicide
NCT00111943 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00111943 |
|---|---|
| Title | Safety and Acceptability of a Vaginal Microbicide |
| Official title | Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | 1% tenofovir gel |
| Enrollment | 200 |
| Completion | Oct 1, 2007 |
| First posted | May 27, 2005 |
| Last update posted | Nov 1, 2021 |
| Countries | India, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: